Roka Bioscience, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 2013, the company has established itself as a key player in the food safety and diagnostics industry, focusing on providing advanced molecular testing solutions. Roka Bioscience's flagship products, including the Atlas® System, offer rapid and accurate detection of pathogens in food and environmental samples, setting them apart with their unique technology and user-friendly design. With a commitment to enhancing food safety, Roka Bioscience serves a diverse range of clients across the food production and processing sectors. The company has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. As a trusted name in food safety diagnostics, Roka Bioscience continues to drive innovation and improve public health outcomes.
How does Roka Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Roka Bioscience, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Roka Bioscience, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Roka Bioscience may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for Roka Bioscience to establish clear climate commitments and reduction initiatives to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roka Bioscience, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
